Trials / Unknown
UnknownNCT03175692
Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 1 Day
- Healthy volunteers
- Not accepted
Summary
Under the joint efforts of genetic and intensive expert, to establish the high-throughput whole exon sequencing(WES) and analysis all the possible pathogenic genes. To provide patient with the appropriate treatment for genetic disease. Besides, it can identify the genetic factor of idiosyncrasy or susceptibility to explain the medical difficulties and give patients personalized advice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Whole Exome Sequencing | Using next generation sequencing to analysis patient's whole exome. To explore the pathogenic gene variation. |
Timeline
- Start date
- 2017-06-14
- Primary completion
- 2018-05-01
- Completion
- 2020-05-01
- First posted
- 2017-06-05
- Last updated
- 2017-06-16
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03175692. Inclusion in this directory is not an endorsement.